TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: PASI improvement of 100% (PASI100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intraocular pressure peaks in the water-drinking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular pressure peaks in the intraocular pressure curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalisation stays
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean change from baseline in monthly migraine days (MMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving ≥ 50% reduction in MMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNP VIA mean scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CNL VIA mean scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: image scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total medical expenditures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Breastfeeding rates
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 6-minute walk distance at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anterior shift of the mandible
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter-related bloodstream infection due to nonfermenting Gram-negative bacilli
Endpoint domain: Adverse events/effects
Primary endpoint: success rate of first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of adverse effect
Endpoint domain: Adverse events/effects
Primary endpoint: NIAPAS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fewer behavioral problems among children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: less child abusive parenting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fewer maternal mental health problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: higher maternal life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improved endoscopic appearance of the sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ostial patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in postoperative infections
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage reduction in FFI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK and PD similarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of binding anti-drug antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Consensus on diagnostic standard and syndrome types for palpitations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in adolescent bullying behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Participation rate in the RCT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall adverse event utility
Endpoint domain: Adverse events/effects
Primary endpoint: mean lumbar vertebral fat fraction (VFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fat saturation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time to the recurrence of uterine contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LTP rates
Endpoint domain: Mortality/survival
Primary endpoint: Time to recurrence (TFS) rates
Endpoint domain: Mortality/survival
Primary endpoint: Mean percent change in HOMA‐%β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Progression to malignant lesions
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of malignant lesions
Endpoint domain: Mortality/survival
Primary endpoint: Patient satisfaction with postoperative analgesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Early PGIC improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Early CGI-TD improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean AIMS total score change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at well-baby visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum R_4β-hydroxycholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum R_lanosterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum R_24,25-dihydrolanosterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ADAS-Cog scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Unplanned telephone contact
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: lower frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: inflammatory markers (C-reactive protein and interleukin-17)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: superior recall of initial learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of secure storage and disposal of unused opioid pills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mini‐AQLQ mean score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Asthma control with ACT score < 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Timing of closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MRA discontinuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SMFA Dysfunction Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SMFA Bother Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Re-rupture rates
Endpoint domain: Adverse events/effects
Primary endpoint: vascular endothelial growth factor (VEGF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Active cervical rotation ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neck pain at maximum cervical rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolongation of QT interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to benefit
Endpoint domain: Mortality/survival
Primary endpoint: Survival probabilities
Endpoint domain: Mortality/survival
Primary endpoint: Onset and peak latencies of conditioned responses (CRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: standard drinks in preceding week/heavy drinking days in preceding week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days with respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lower oxygen demand (FiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of NCPAP support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Apnea of prematurity (AOP)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of intraventricular hemorrhage (IVH)
Endpoint domain: Adverse events/effects
Primary endpoint: FS-14 score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of subretinal fibrosis
Endpoint domain: Mortality/survival
Primary endpoint: Number of ulcers healed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nutritional performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VT distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fear values
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral functioning
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: risk of pronation-related running injuries
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in HAMD-24 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of anxiety/somatization factor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum sodium concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PAC-QOL score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PAC-SYM score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thickness of the upper trapezius muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: perceived accuracy of pelvic fracture identification
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: understanding of injury mechanism
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: learning interest and motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: subjective feelings of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean VAS ratings for needle insertion pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS ratings for solution deposition pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of moderate/severe pain for needle insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of moderate/severe pain for solution deposition
Endpoint domain: Adverse events/effects
Primary endpoint: Torque at failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collected bone graft amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician‐Administered PTSD Scale for DSM‐5 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kidney composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in UACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of intestinal permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kneeling difficulty and pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum testosterone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum oestradiol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left eye pupil constriction difference between direct and consensual stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean extra charge regarding total intraoperative costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost of surgical instruments per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful VBAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: AFEQT summary score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AF-specific symptom recurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Valid swab collection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Size of tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of malignant cells in tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reductions in WHO risk levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perceived nursing performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: MCFA flexion recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade of discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: KCCQ TSS improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 1-year graft patency
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in sulcus bleeding index (SBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about constituent health effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceptions of constituent variability in SLT products
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ratings of disease risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvement in postoperative physical functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total two‐year proximal head penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steady‐state volumetric wear rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annual eGFR decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Demineralization indicated by ΔZ&LD values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remineralization indicated by ΔZ values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic knee flexion power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Countermovement jump performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Thrombotic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: DIC (Disseminated Intravascular Coagulation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: time to TB treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean heart rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum anteroposterior diameter of uterine hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days required to treat uterine contraction pain
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: percentage of honored consultation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of thrombotic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Veterans using home dialysis at 90-days post-kidney failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean SDw of glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TIR 70-180 mg/dL glucose increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: oxygen dependency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurodevelopmental quotients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physician-rated NSICU nursing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year outcome rate in primary cohort
Endpoint domain: Mortality/survival
Primary endpoint: tutor-rated patient-centeredness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tutor-rated overall consultation skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-rated rapport
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in nocturia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PIVC skill scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PIVC knowledge levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical symptom improvement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function (PF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Feeling of panic
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Odds of recruitment into the trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in NT-proBNP levels from baseline to 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of postprandial reflux events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prognosis in ischemic stroke patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-reactive protein test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thiol groups levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appropriate weight gain rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suppression of an increase in fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: increase in pregnancy stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: onset and severity of urinary incontinence (UI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of esophageal strictures
Endpoint domain: Adverse events/effects
Primary endpoint: post-operative irritative symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: urinary infections
Endpoint domain: Adverse events/effects
Primary endpoint: Dentine erosion prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction rate of aesthetics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MMP-9/proMMP-9 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to change behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 30-day anastomotic leak rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: First-pass isolation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Freedom from atrial arrhythmia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of CI-AKI development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: peak vGRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under curves (AUCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to loss of PASI 75 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strephenopodia angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Holden FAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thickness of anterior and posterior tibia muscle on affected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Intrahepatic fat percentage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pancreatic fat percentage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cultural competence scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status